Continuing Education Program: Online CME: Rheumatology CME: New Frontiers of Biologic Therapies for RA: Comparing and Contrasting Existing and Emerging Biologics: National Association for Continuing Education (NACE): Oct 12, 2009 - Oct 11, 2011
http://www.cmenetworks.com/cme/11580/1/Continuing-Education-Program-Online-CME-Rheumatology-CME-New-Frontiers-of-Biologic-Therapies-for-RA-Comparing-and-Contrasting-Existing-and-Emerging-Biologics-National-Association-for-Continuing-Education-NACE-Oct-12-2009---Oct-11-2011/Page1.html
National Association for Continuing Education (NACE)
The mission of the National Association for Continuing Education (NACE) is to offer continuing education opportunities to provide learners in the fields of medicine, behavioral health, education, and related disciplines, with the most up-to-date, science-based information that will enable them to maintain or increase their knowledge, skills, and professional performance to ultimately benefit the public’s health.
By National Association for Continuing Education (NACE)
Published on 05/27/2010
New Frontiers of Biologic Therapies for RA: Comparing and Contrasting Existing and Emerging Biologics
National Association for Continuing Education (NACE)
October 12, 2009 - October 11, 2011
Welcome to the National Association for Continuing Education webcast of our New Perspectives in the Management of Rheumatic Diseases: Update 2009. The topic of this webcast is New Frontiers of Biologic Therapies for RA: Comparing and Contrasting Existing and Emerging Biologics.
CME Sponsor:
National Association for Continuing Education (NACE)
Location:
Online CME
Course Instructors/Directors:
Arthur Weaver, MD, MS (disclosures included)
Alan Brown, MD
Jefrey Lieberman, MD, FACP
Harvey Parker, PhD
Michelle Frisch, MPH
Alan Goodstat, LCSW
Number of Credits:
1 AMA PRA Category 1 Credits™
Registration Fee:
Free
More Info
Detailed Description:
Welcome to the National Association for Continuing Education webcast of our New Perspectives in the Management of Rheumatic Diseases: Update 2009. The topic of this webcast is New Frontiers of Biologic Therapies for RA: Comparing and Contrasting Existing and Emerging Biologics.
The program was captured live in Hallandale, Florida on September 26, 2009 and features Dr. Arthur Weaver. Dr. Weaver is Clinical Professor of Medicine Emeritus, Section of Rheumatology at the University of Nebraska Medical Center in Omaha, Nebraska.
Learning Objectives:
After completing this program participants should be able to:
New Frontiers of Biologic Therapies for RA: Comparing and Contrasting Existing and Emerging Biologics
National Association for Continuing Education (NACE)
October 12, 2009 - October 11, 2011
Welcome to the National Association for Continuing Education webcast of our New Perspectives in the Management of Rheumatic Diseases: Update 2009. The topic of this webcast is New Frontiers of Biologic Therapies for RA: Comparing and Contrasting Existing and Emerging Biologics.
New Frontiers of Biologic Therapies for RA: Comparing and Contrasting Existing and Emerging Biologics
CME Sponsor:
National Association for Continuing Education (NACE)
Location:
Online CME
Course Instructors/Directors:
Arthur Weaver, MD, MS (disclosures included)
Alan Brown, MD
Jefrey Lieberman, MD, FACP
Harvey Parker, PhD
Michelle Frisch, MPH
Alan Goodstat, LCSW
Number of Credits:
1 AMA PRA Category 1 Credits™
Registration Fee:
Free
More Info
Detailed Description:
Welcome to the National Association for Continuing Education webcast of our New Perspectives in the Management of Rheumatic Diseases: Update 2009. The topic of this webcast is New Frontiers of Biologic Therapies for RA: Comparing and Contrasting Existing and Emerging Biologics.
The program was captured live in Hallandale, Florida on September 26, 2009 and features Dr. Arthur Weaver. Dr. Weaver is Clinical Professor of Medicine Emeritus, Section of Rheumatology at the University of Nebraska Medical Center in Omaha, Nebraska.
Learning Objectives:
After completing this program participants should be able to:
- List various biologic therapies undergoing clinical development
- Explain the mechanisms of action of emerging biologic therapies
- Compare and contrast existing and forthcoming biologic therapies
- Evaluate potential consequences of treatment with new biologic agents